A detailed history of Sjs Investment Consulting Inc. transactions in Incyte Corp stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 28 shares of INCY stock, worth $1,989. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 22 27.27%
Holding current value
$1,989
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$57.33 - $68.61 $343 - $411
6 Added 27.27%
28 $1,000
Q2 2024

Jul 16, 2024

BUY
$51.18 - $63.75 $204 - $255
4 Added 22.22%
22 $1,000
Q4 2023

Jan 16, 2024

SELL
$52.16 - $64.19 $365 - $449
-7 Reduced 28.0%
18 $1,000
Q3 2023

Oct 17, 2023

BUY
$57.77 - $65.93 $288 - $329
5 Added 25.0%
25 $1,000
Q2 2023

Jul 13, 2023

BUY
$60.95 - $75.51 $182 - $226
3 Added 17.65%
20 $1,000
Q1 2023

Apr 20, 2023

SELL
$70.23 - $86.01 $351 - $430
-5 Reduced 22.73%
17 $1,000
Q4 2022

Jan 23, 2023

SELL
$67.18 - $84.11 $201 - $252
-3 Reduced 12.0%
22 $0
Q3 2022

Oct 13, 2022

BUY
$66.18 - $82.86 $1,455 - $1,822
22 Added 733.33%
25 $2,000
Q1 2022

May 05, 2022

BUY
$66.02 - $79.71 $198 - $239
3 New
3 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sjs Investment Consulting Inc. Portfolio

Follow Sjs Investment Consulting Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sjs Investment Consulting Inc. with notifications on news.